Successful treatment of severe cytokine release syndrome after CAR-T therapy by ruxolitinib without compromising CAR-T efficacy

被引：5
作者：
Gu, Chengyuan [1 ,2 ,3 ]
Wu, Qian [1 ,2 ,3 ]
Zhang, Jingren [1 ,2 ,3 ]
Kang, Liqing [4 ,5 ]
Yu, Lei [4 ,5 ]
Qiu, Huiying [1 ,2 ,3 ]
Wu, Depei [1 ,2 ,3 ]
Chen, Suning [1 ,2 ,3 ]
Yang, Xiaofei [1 ,2 ,3 ,6 ]
机构：
[1] Soochow Univ, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol, Affiliated Hosp 1, Suzhou, Peoples R China
[2] Inst Blood & Marrow Transplantat, Suzhou, Peoples R China
[3] Soochow Univ, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[4] East China Normal Univ, Sch Chem & Mol Engn, Shanghai, Peoples R China
[5] Shanghai Unicar Therapy Biomed Technol Co Ltd, Shanghai, Peoples R China
[6] oochow Univ, Jiangsu Inst Hematol, Natl Clin Res Ctr Hematol Dis, Affiliated Hosp 1, Suzhou 215000, Peoples R China
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷 / 02期
基金：
国家重点研发计划; 中国国家自然科学基金;
关键词：
D O I：
10.1080/10428194.2022.2148209
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：495 / 498
页数：4
相关论文
共 50 条
  • [31] EFFICACY OF PREDICTING CYTOKINE RELEASE SYNDROME IN CAR-T THERAPY RECIPIENTS WITH EASIX SCORES: DLBCL VS MULTIPLE MYELOMA
    Raavi, Lekhya
    Jonna, Sadhana
    Huespe, Ivan
    Isha, Shahin
    Nataraja, Hrishikesh
    Jenkins, Anna
    Hanson, Abby
    Balasubramanian, Prasanth
    Balavenkataraman, Arvind
    Shuman, Midiia
    Murthy, Hemant
    Sanghavi, Devang
    [J]. CHEST, 2024, 166 (04) : 2429A - 2430A
  • [32] CAR-T Cell Therapy: the Efficacy and Toxicity Balance
    Chohan, Karan L.
    Siegler, Elizabeth L.
    Kenderian, Saad S.
    [J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (02) : 9 - 18
  • [33] Impacts of ageing on the efficacy of CAR-T cell therapy
    Qi, Shimao
    Li, Jiaqian
    Gu, Xinyu
    Zhang, Yalan
    Zhou, Weilin
    Wang, Fengling
    Wang, Wei
    [J]. AGEING RESEARCH REVIEWS, 2025, 107
  • [34] Efficacy and safety of CAR-T cell therapy in minorities
    Thakkar, Astha
    Abreu, Michelly
    Pradhan, Kith
    Sica, R. Alejandro
    Shastri, Aditi
    Kornblum, Noah
    Shah, Nishi
    Mantzaris, Ioannis
    Gritsman, Kira
    Feldman, Eric
    Elkind, Richard
    Green-Lorenzen, Susan
    Verma, Amit
    Braunschweig, Ira
    Goldfinger, Mendel
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (07) : 1187 - 1190
  • [35] Efficacy and safety of CAR-T cell therapy in minorities
    Astha Thakkar
    Michelly Abreu
    Kith Pradhan
    R. Alejandro Sica
    Aditi Shastri
    Noah Kornblum
    Nishi Shah
    Ioannis Mantzaris
    Kira Gritsman
    Eric Feldman
    Richard Elkind
    Susan Green-Lorenzen
    Amit Verma
    Ira Braunschweig
    Mendel Goldfinger
    [J]. Bone Marrow Transplantation, 2022, 57 : 1187 - 1190
  • [36] CAR-T Cell Therapy: the Efficacy and Toxicity Balance
    Karan L. Chohan
    Elizabeth L. Siegler
    Saad S. Kenderian
    [J]. Current Hematologic Malignancy Reports, 2023, 18 : 9 - 18
  • [37] Quelling the Cytokine Storms during CAR-T Cell Therapy
    YAN Fusheng
    [J]. Bulletin of the Chinese Academy of Sciences, 2023, 37 (03) : 150 - 151
  • [38] CAR-T efficacy: is conditioning the key?
    Neelapu, Sattva S.
    [J]. BLOOD, 2019, 133 (17) : 1799 - 1800
  • [39] Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy
    Moriyama, Shohei
    Fukata, Mitsuhiro
    Yokoyama, Taku
    Ueno, Shohei
    Nunomura, Takuya
    Mori, Yasuo
    Kato, Koji
    Miyamoto, Toshihiro
    Akashi, Koichi
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [40] Coexistence of a Huge Venous Thromboembolism and Bleeding Tendency in Cytokine Release Syndrome during CAR-T Therapy
    Liu, Haiyan
    Yang, Ye
    Huang, Hongming
    [J]. BLOOD, 2019, 134
12345